Enhanced cardiovascular morbidity and mortality during rhythm control treatment in persistent atrial fibrillation in hypertensives: data of the RACE study.
about
Rationale and current perspective for early rhythm control therapy in atrial fibrillation.The Utility of Ambulatory Electrocardiographic Monitoring for Detecting Silent Arrhythmias and Clarifying Symptom Mechanism in an Urban Elderly Population with Heart Failure and Hypertension: Clinical Implications.Drug therapy in atrial fibrillation management: where do we stand in 2010?Angiotensin-converting enzyme gene 2350 G/A polymorphism and susceptibility to atrial fibrillation in Han Chinese patients with essential hypertensionPharmacologic rate versus rhythm-control strategies in atrial fibrillation: an updated comprehensive review and meta-analysis.Comparative effectiveness of antiarrhythmic drugs on cardiovascular hospitalization and mortality in atrial fibrillation.The effects of rhythm control strategies versus rate control strategies for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and Trial Sequential Analysis.Hypertension and cardiac arrhythmias: a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad LatinoamFunctional polymorphisms in ACE and CYP11B2 genes and atrial fibrillation in patients with hypertensive heart disease.
P2860
Q27692632-3615B7B9-670D-41D1-BFF2-2229739B9431Q33585631-15EAF46D-7EE3-4F5D-9515-92DF2E2EF440Q36305013-FBA52765-C990-437D-88B6-C98C19DD37F2Q37266655-1F87755F-D4EB-4A0E-B78A-98364DAEFBFEQ38043541-DE73F304-3BC2-4E0A-BAD5-AEF6D09B2D98Q38162889-072D803C-A826-4A3A-B678-6DEC6649E1D3Q44824832-446C3CF5-99F9-4569-B70C-F7FDB64AED90Q47775639-3286E1E2-49A1-46DD-B446-A6EBCA96B41FQ54500829-23ADEA35-6748-4532-9892-69E8E6DDE3AC
P2860
Enhanced cardiovascular morbidity and mortality during rhythm control treatment in persistent atrial fibrillation in hypertensives: data of the RACE study.
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Enhanced cardiovascular morbid ...... sives: data of the RACE study.
@ast
Enhanced cardiovascular morbid ...... sives: data of the RACE study.
@en
type
label
Enhanced cardiovascular morbid ...... sives: data of the RACE study.
@ast
Enhanced cardiovascular morbid ...... sives: data of the RACE study.
@en
prefLabel
Enhanced cardiovascular morbid ...... sives: data of the RACE study.
@ast
Enhanced cardiovascular morbid ...... sives: data of the RACE study.
@en
P2093
P356
P1476
Enhanced cardiovascular morbid ...... nsives: data of the RACE study
@en
P2093
Dirk J Van Veldhuisen
Harry J G M Crijns
RACE Investigators
P304
P356
10.1093/EURHEARTJ/EHL436
P577
2007-02-01T00:00:00Z